1-Aminomethyl-5-methoxyindane


1-Aminomethyl-5-methoxyindane, is a drug developed by a team led by David E. Nichols at Purdue University, which acts as a selective serotonin releasing agent and binds to the serotonin transporter with similar affinity to DFMDA.